medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (2)

Rosaceiform tuberculid of Lewandowsky: a challenging diagnosis

Zúñiga REY, Galván LFB, Abarca DDL, Alcántara RVD, Gutiérrez ÁSA, Guerrero HDV
Full text How to cite this article

Language: Spanish
References: 15
Page: 117-120
PDF size: 233.75 Kb.


Key words:

cutaneous tuberculosis, nodular tuberculid of the face, rosacea-like tuberculid.

ABSTRACT

Cutaneous tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis. Nodular tuberculid of the face, also known as Lewandowsky’s rosacea-like tuberculid, is a rare variant of cutaneous tuberculosis, accounting for less than 1% of all cases. We present a 47-year-old immunocompetent male with a dermatosis characterized by papular and some nodular lesions in the central facial region. Initially misdiagnosed as rosacea due to inadequate response to standard treatment, a subsequent histopathological study revealed tuberculoid granuloma formation. This prompted a purified protein derivative (PPD) test, which was positive at 72 hours, confirming the diagnosis of Lewandowsky’s rosacea- like tuberculid. A search for systemic tuberculosis yielded no evidence of extracutaneous involvement. The patient responded favorably to anti-tuberculosis treatment.


REFERENCES

  1. Natarajan A, Beena PM, Devnikar AV y Mali S, A systemicreview on tuberculosis, Indian Journal of Tuberculosis 2020;67:295-311.

  2. Conlledo R, Guglielmetti A, Sobarzo M, Woolvett F, Bravo F,González S et al., Lewandowsky’s rosaceiform eruption: a formof cutaneous tuberculosis confirmed by pcr in two patients,Dermatol Ther (Heidelberg) 2015; 5:67-76.

  3. Lai-Cheong JE, Pérez A, Tang V, Martínez A, Hill V y MenagéHDP, Cutaneous manifestations of tuberculosis, Clin Exp Dermatol2007; 32:461-6.

  4. Kaul S, Kaur I, Mehta S y Singal A, Cutaneous tuberculosis. Parti: Pathogenesis, classification, and clinical features, Journal ofthe American Academy of Dermatology 2023; 89:1091-103.

  5. Bobbio L y Vivanco E, Tubercúlide nodular de la cara: presentaciónde un caso, Dermatol Perú 2017; 27(I):35-8.

  6. Navarrete G, Tubercúlides de la cara: una expresión diferente dela tuberculosis, Gac Med Méx 2003; 139(1):36-7.

  7. Kumakawa Z, Santos R, Álvarez P, Angulo N, Meza B y León A,Nuevo espectro de tubercúlide papulosa: aspectos clínicos ehistopatológicos a propósito de un caso, Folia Dermatol Perú2010; 21(1):25-9.

  8. Güere P, Paredes A, Pacheco M, Carbajal T y Bravo F, Tubercúlidepapular o tuberculosis cutánea paucibacilar: reporte de caso,Folia Dermatol Perú 2011; 22(2):81-4.

  9. Chougule A, Chatterjee D, Yadav R, Sethi S, De D y Saikia UN,Granulomatous rosacea versus lupus miliaris disseminatus faciei—2 faces of facial granulomatous disorder: a clinicohistologicaland molecular study, The American Journal of Dermatopathology2018; 40:819-23.

  10. Abdelghaffar M, Hwang E y Damsky W, Cutaneous sarcoidosis,Clinics in Chest Medicine 2024; 45:71-89.

  11. Caplan A, Rosenbach M e Imadojemu S, Cutaneous sarcoidosis,Semin Respir Crit Care Med 2020; 41:689-99.

  12. Kaul S, Jakhar D, Mehta S y Singal A, Cutaneous tuberculosis.Part ii: Complications, diagnostic workup, histopathologic features,and treatment, Journal of the American Academy of Dermatology2023; 89:1107-19.

  13. Abdalla CMZ, De Oliveira ZNP, Sotto MN, Leite KRM, CanavezFC y De Carvalho CM, Polymerase chain reaction compared toother laboratory findings and to clinical evaluation in the diagnosisof cutaneous tuberculosis and atypical mycobacteria skininfection, Int J Dermatology 2009; 48:27-35.

  14. Dhattarwal N y Ramesh V, Tuberculids: a narrative review, IndianDermatol Online J 2023; 14:320.

  15. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, CattamanchiA et al., Official American Thoracic Society/Centers forDisease Control and Prevention/Infectious Diseases Society ofAmerica Clinical Practice Guidelines: treatment of drug-susceptibletuberculosis, Clinical Infectious Diseases 2016; 63:e147-95.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2025;23